Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$45.2K Sell
28,760
-136,797
-83% -$247K ﹤0.01% 4359
2025
Q4
$306K Buy
165,557
+21,847
+15% +$38K ﹤0.01% 4119
2025
Q3
$230K Sell
143,710
-37,967
-21% -$69.4K ﹤0.01% 4236
2025
Q2
$316K Buy
181,677
+76,064
+72% +$127K ﹤0.01% 4022
2025
Q1
$253K Sell
105,613
-58,702
-36% -$192K ﹤0.01% 3915
2024
Q4
$582K Buy
164,315
+21,100
+15% +$83.5K ﹤0.01% 3731
2024
Q3
$606K Buy
143,215
+109,236
+321% +$472K ﹤0.01% 3653
2024
Q2
$127K Sell
33,979
-48,946
-59% -$223K ﹤0.01% 3793
2024
Q1
$449K Sell
82,925
-62,373
-43% -$359K ﹤0.01% 3662
2023
Q4
$896K Buy
145,298
+113,170
+352% +$557K ﹤0.01% 3516
2023
Q3
$167K Sell
32,128
-2,067
-6% -$11K ﹤0.01% 3381
2023
Q2
$172K Sell
34,195
-4,778
-12% -$19.4K ﹤0.01% 3318
2023
Q1
$143K Buy
38,973
+17,806
+84% +$67.2K ﹤0.01% 3980
2022
Q4
$76.2K Buy
+21,167
New +$111K ﹤0.01% 4382

Other funds holding OABI

Barclays's OABI Position: Q1 2026 in Review

Barclays reduced its OmniAb (OABI) stake by 83% in Q1 2026, selling an estimated $247K and leaving 28,760 shares worth $45.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4359.

Barclays first reported a position in OABI in Q4 2022 and has held it in 14 quarters since. The position peaked at $896K in Q4 2023. 128 funds tracked by Wall St. Rank hold OABI as of Q1 2026.

  • Barclays held 28,760 shares of OmniAb worth $45.2K as of Q1 2026.
  • Barclays sold 136,797 OmniAb shares in Q1 2026, an estimated $247K.
  • OmniAb made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4359 holding.
  • Barclays first reported a position in OmniAb in Q4 2022 and has held it in 14 quarters since.
  • Barclays's OmniAb position peaked at $896K in Q4 2023.
  • 128 funds tracked by Wall St. Rank held OmniAb as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.